Basotest and suxamethonium allergy.
Aly Hassan
I M
IM
Regional Immunology Service, Royal Group of Hospitals, Belfast BT12 6BN, Northern Ireland, UK. a.crockard@qub.ac.uk
Crockard
A D
AD
Asghar
M S
MS
Edgar
J D
JD
Atkinson
S
S
D000328:Adult; D000707:Anaphylaxis / Q000139:chemically induced / Q000175:diagnosis*; D015703:Antigens, CD / Q000032:analysis*; D001491:Basophils / Q000276:immunology*; D004306:Dose-Response Relationship, Immunologic; D004342:Drug Hypersensitivity / Q000175:diagnosis* / Q000209:etiology; D005260:Female; D005434:Flow Cytometry / Q000379:methods*; D006801:Humans; D066298:In Vitro Techniques; D009467:Neuromuscular Depolarizing Agents / Q000009:adverse effects* / Q000276:immunology; D010980:Platelet Membrane Glycoproteins / Q000032:analysis*; D013390:Succinylcholine / Q000009:adverse effects* / Q000276:immunology; D060149:Tetraspanin 30
D015703:Antigens, CD; C554586:CD63 protein, human; D009467:Neuromuscular Depolarizing Agents; D010980:Platelet Membrane Glycoproteins; D060149:Tetraspanin 30; D013390:Succinylcholine